These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36795878)

  • 1. Imaging in Movement Disorders.
    Maiti B; Perlmutter JS
    Continuum (Minneap Minn); 2023 Feb; 29(1):194-218. PubMed ID: 36795878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease.
    Furukawa K; Shima A; Kambe D; Nishida A; Wada I; Sakamaki H; Yoshimura K; Terada Y; Sakato Y; Mitsuhashi M; Sawamura M; Nakanishi E; Taruno Y; Yamakado H; Fushimi Y; Okada T; Nakamoto Y; Takahashi R; Sawamoto N
    Ann Neurol; 2022 Jul; 92(1):110-121. PubMed ID: 35428994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo measures of nigrostriatal neuronal response to unilateral MPTP treatment.
    Tian L; Karimi M; Brown CA; Loftin SK; Perlmutter JS
    Brain Res; 2014 Jul; 1571():49-60. PubMed ID: 24845719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.
    Horowitz T; Grimaldi S; Azulay JP; Guedj E
    Rev Neurol (Paris); 2022 May; 178(5):484-489. PubMed ID: 35527085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging in Parkinsonian Disorders.
    Tripathi M; Kumar A; Bal C
    Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.
    Lee JY; Martin-Bastida A; Murueta-Goyena A; Gabilondo I; Cuenca N; Piccini P; Jeon B
    Nat Rev Neurol; 2022 Apr; 18(4):203-220. PubMed ID: 35177849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders.
    Akdemir ÜÖ; Bora Tokçaer A; Atay LÖ
    Turk J Med Sci; 2021 Apr; 51(2):400-410. PubMed ID: 33237660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.
    Bohnen NI; Frey KA; Studenski S; Kotagal V; Koeppe RA; Constantine GM; Scott PJ; Albin RL; Müller ML
    Mov Disord; 2014 Aug; 29(9):1118-24. PubMed ID: 24909584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson Disease: A Review.
    Mitchell T; Lehéricy S; Chiu SY; Strafella AP; Stoessl AJ; Vaillancourt DE
    JAMA Neurol; 2021 Oct; 78(10):1262-1272. PubMed ID: 34459865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal Component Analysis of Multimodal Neuromelanin MRI and Dopamine Transporter PET Data Provides a Specific Metric for the Nigral Dopaminergic Neuronal Density.
    Kawaguchi H; Shimada H; Kodaka F; Suzuki M; Shinotoh H; Hirano S; Kershaw J; Inoue Y; Nakamura M; Sasai T; Kobayashi M; Suhara T; Ito H
    PLoS One; 2016; 11(3):e0151191. PubMed ID: 26954690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging the Substantia Nigra in Parkinson Disease and Other Parkinsonian Syndromes.
    Bae YJ; Kim JM; Sohn CH; Choi JH; Choi BS; Song YS; Nam Y; Cho SJ; Jeon B; Kim JH
    Radiology; 2021 Aug; 300(2):260-278. PubMed ID: 34100679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.
    Bae YJ; Kim JM; Kim E; Lee KM; Kang SY; Park HS; Kim KJ; Kim YE; Oh ES; Yun JY; Kim JS; Jeong HJ; Jeon B; Kim SE
    Mov Disord; 2016 May; 31(5):684-92. PubMed ID: 26990970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].
    Arbizu J; Luquin MR; Abella J; de la Fuente-Fernández R; Fernandez-Torrón R; García-Solís D; Garrastachu P; Jiménez-Hoyuela JM; Llaneza M; Lomeña F; Lorenzo-Bosquet C; Martí MJ; Martinez-Castrillo JC; Mir P; Mitjavila M; Ruiz-Martínez J; Vela L
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):215-26. PubMed ID: 24731551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging of the Dopamine Transporter.
    Palermo G; Ceravolo R
    Cells; 2019 Aug; 8(8):. PubMed ID: 31405186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.